Loading clinical trials...
Loading clinical trials...
This trial intends to test the efficacy and safety of RAD001 in patients with advanced sarcoma who failed to conventional chemotherapy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Asan Medical Center
Collaborators
NCT07215611 · Bone Sarcomas, Financial Toxicity
NCT04506008 · Soft Tissue Sarcomas
NCT06644287 · Advanced Soft Tissue Sarcomas
NCT07136571 · Soft Tissue Sarcomas
NCT01710176 · Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do
Asan Medical Center, University of Ulsan College of Medicine
Seoul, N/A = Not Applicable
Yeongnam University College of Medicine
Daegu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions